CLAUDIA SCHLOSBERG for FOREST LABORATORIES INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2900, Prescription Drug User Fee Reauthorization Act, (treatment of certain enantiomer drugs; S. 1082, FDA Revitalization Act, Sec. 264, (treatment of certain enantiomer drugs).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAUDIA ELLEN SCHLOSBERG | N/A |
Medicare/Medicaid MMM
H.R. 3025, Medicare Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, Coverage of mental health drugs under Medicare part D;, H.R. 3162, Children's Health and Medicare Protection Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare Part D; S.3 Access to Critical Medications under Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAUDIA ELLEN SCHLOSBERG | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.